XML 108 R31.htm IDEA: XBRL DOCUMENT v3.25.3
Basis of Presentation and Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Product Information [Line Items]          
Professional fees   $ 82,000   $ 336,000  
Accounts Receivable, Allowance for Credit Loss, Current $ 1,014,000   $ 1,014,000   $ 1,613,000
Receivables, Net, Current 4,139,000   4,139,000   3,068,000
Allowance for loans losses 7,478,000   7,478,000   9,406,000
Inventory adjustments 131,000   131,000   180,000
Goodwill 1,769,000   1,769,000   1,769,000
Impairment of intangible assets $ 600,000  
Antidilutive securities     0 0  
Cash and cash equivalents $ 7,000,000.0   $ 7,000,000.0    
Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale     $ 1,600,000    
Premier Packaging Company [Member]          
Product Information [Line Items]          
Goodwill         1,769,000
Impact BioMedical, Inc. [Member]          
Product Information [Line Items]          
Goodwill         $ 25,093,000
Customer One [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]          
Product Information [Line Items]          
Concentration risk, percentage     25.00% 20.00% 22.00%
Customer One [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]          
Product Information [Line Items]          
Concentration risk, percentage     36.00% 26.00% 29.00%
Customer Two [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]          
Product Information [Line Items]          
Concentration risk, percentage       10.00% 13.00%
Customer Two [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]          
Product Information [Line Items]          
Concentration risk, percentage     10.00% 23.00% 20.00%